Novo Nordisk A/S (NOVA:MUN) financials, including income statements, growth rates, balance sheets and cash flow information.
Novo Nordisk A/S + Add to watchlist NOV:HAN Actions Price (EUR)81.67 Today's Change0.47 / 0.58% Shares traded200.00 1 Year change-23.17% Beta-- Data delayed at least 15 minutes, as of Jan 31 2025 16:25 GMT. Find More Stocks Use our equities screener to discover other potential ...
Get Novo Nordisk A/S (NVO:NYSE) real-time stock quotes, news, price and financial information from CNBC.
This makes Novo Nordisk the world's 11th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth....
Novo Nordisk (NYSE:NVO) Stock Surges on Obesity Drug Trial 19h ago LLY NVO The Fly Novo Nordisk shares jump on phase 1b/2a subcutaneous amycretin trial results 20h ago NVO Market News Allurion Stock Skyrockets on Weight-Loss Study Buzz ...
Explore the ever-changing world of NOVO-NORDISK A-S-SPONS ADR shares on FxPro. Get the latest information on the real-time share price, market performance, and economic insights. Understand NOVO-NORDISK A-S-SPONS ADR's market position with our detailed analysis, featuring historical data and ...
Novo Nordisk’s shares are declining due to lower-than-expected results for the second quarter of 2024. Year to date, shares of NVO have climbed 25.8% compared with theindustry’s 15.8% growth. Image Source: Zacks Investment Research
NOVO.B | Complete Novo Nordisk A/S stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Price to Earnings (P/E)33.2 Beta0.53 Next Earnings Feb 05, 2025 EPS Estimate $0.89 Last Dividend Ex-Date Aug 16, 2024 Dividend Yield1% Show more Novo Nordisk News The Fly Novo Nordisk placed on ‘Positive Catalyst Watch’ at JPMorgan ...
TechnologyThese Stocks Moved the Most Today: Apple, Alphabet, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, and More Jan. 17, 2025 at 4:44 p.m. ETby Barron's Biotech and PharmaMedicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out. ...